Statistics

Total Visits

Views
Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial11

Select a period of time:

Number of views in the range

Views
Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial7

Views

Views
October 20231
November 20232
December 20230
January 20241
February 20241
March 20242
April 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
 

Top cities views

Views
Ashburn2
Boardman1